| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615650 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 22 Pages |
Abstract
Danazol as first-line therapy is an acceptable treatment option with low side effects for patients with MDS who cannot receive ASCT.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Perla RocÃo Colunga-Pedraza, Julia Esther Colunga-Pedraza, MarÃa Alejandra Garza-Ledezma, Jose Carlos Jaime-Pérez, Olga Graciela Cantú-RodrÃguez, César Homero Gutiérrez-Aguirre, Erick Joel Rendón-RamÃrez, Yadith Karina López-GarcÃa,